Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AVTR logo AVTR
Upturn stock rating
AVTR logo

Avantor Inc (AVTR)

Upturn stock rating
$14.78
Last Close (24-hour delay)
Profit since last BUY7.26%
upturn advisory
Consider higher Upturn Star rating
BUY since 5 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/17/2025: AVTR (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

21 Analysts rated it

Well-followed company, solid analyst reports, reliable data for confident investing.

1 Year Target Price $14.4

1 Year Target Price $14.4

Analysts Price Target For last 52 week
$14.4 Target price
52w Low $10.82
Current$14.78
52w High $24.86

Analysis of Past Performance

Type Stock
Historic Profit -11.12%
Avg. Invested days 26
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/17/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 10.08B USD
Price to earnings Ratio 14.63
1Y Target Price 14.4
Price to earnings Ratio 14.63
1Y Target Price 14.4
Volume (30-day avg) 21
Beta 0.98
52 Weeks Range 10.82 - 24.86
Updated Date 10/18/2025
52 Weeks Range 10.82 - 24.86
Updated Date 10/18/2025
Dividends yield (FY) -
Basic EPS (TTM) 1.01

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 10.31%
Operating Margin (TTM) 7.63%

Management Effectiveness

Return on Assets (TTM) 3.24%
Return on Equity (TTM) 11.73%

Valuation

Trailing PE 14.63
Forward PE 13.93
Enterprise Value 13180641554
Price to Sales(TTM) 1.51
Enterprise Value 13180641554
Price to Sales(TTM) 1.51
Enterprise Value to Revenue 1.98
Enterprise Value to EBITDA 9.34
Shares Outstanding 681738675
Shares Floating 663945296
Shares Outstanding 681738675
Shares Floating 663945296
Percent Insiders 1.37
Percent Institutions 105.97

ai summary icon Upturn AI SWOT

Avantor Inc

stock logo

Company Overview

overview logo History and Background

Avantor, Inc., traces its roots back to 1904. Originally focused on laboratory equipment, it has evolved into a leading global provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Key milestones include strategic acquisitions that expanded its product portfolio and global reach.

business area logo Core Business Areas

  • Materials and Consumables: Offers a wide range of high-purity chemicals, lab consumables, customized solutions, and single-use technologies vital for research, development, and manufacturing processes.
  • Equipment and Instrumentation: Provides laboratory and production equipment, instruments, and related services, including maintenance, repair, and calibration.
  • Services and Solutions: Offers a range of services, including laboratory and process design, validation, and sourcing solutions, aiding customers in improving productivity and efficiency.

leadership logo Leadership and Structure

Avantor is led by a team of experienced executives and operates with a global structure. Michael Stubblefield is the President and CEO. The company has a board of directors that provides oversight and strategic guidance.

Top Products and Market Share

overview logo Key Offerings

  • Single-Use Solutions: Single-use technologies are used in biopharmaceutical manufacturing processes, offering flexibility and reduced contamination risk. Competitors include Thermo Fisher Scientific and Sartorius. Market share data is difficult to pinpoint precisely but Avantor is a top player in this segment with estimated revenue in the billions.
  • High-Purity Chemicals: Manufactures and distributes high-purity chemicals used in research and manufacturing. Competitors include Merck KGaA and Honeywell. Market share data is difficult to pinpoint precisely but Avantor is a top player in this segment with estimated revenue in the hundreds of millions.
  • Lab Products: Distributes a wide range of lab products (e.g. filtration) used in research and manufacturing. Competitors include Thermo Fisher Scientific and VWR. Market share data is difficult to pinpoint precisely but Avantor is a top player in this segment with estimated revenue in the hundreds of millions.

Market Dynamics

industry overview logo Industry Overview

The life sciences and advanced technologies industries are experiencing growth driven by increasing R&D spending, demand for biopharmaceuticals, and advancements in materials science. The industry is competitive and highly regulated.

Positioning

Avantor is positioned as a leading global provider of solutions to the life sciences and advanced technologies industries. Its competitive advantage lies in its broad product portfolio, global reach, and ability to provide customized solutions.

Total Addressable Market (TAM)

The TAM for the life sciences and advanced technologies market is substantial, estimated in the hundreds of billions of dollars. Avantor is well-positioned to capture a significant share of this market through its diverse offerings and strategic partnerships.

Upturn SWOT Analysis

Strengths

  • Global Reach
  • Broad Product Portfolio
  • Strong Customer Relationships
  • Customized Solutions
  • Strategic Acquisitions

Weaknesses

  • High Debt Levels
  • Exposure to Economic Cycles
  • Integration Risks from Acquisitions
  • Dependence on Key Suppliers

Opportunities

  • Growing Demand for Biopharmaceuticals
  • Expansion in Emerging Markets
  • Increasing R&D Spending
  • Digital Transformation
  • Strategic Partnerships

Threats

  • Intense Competition
  • Regulatory Changes
  • Economic Downturns
  • Supply Chain Disruptions
  • Rising Raw Material Costs

Competitors and Market Share

competitor logo Key Competitors

  • TMO
  • DHR
  • SYK
  • BIO

Competitive Landscape

Avantor competes with larger, more diversified companies. Its competitive advantage lies in its focus on specific customer segments and its ability to provide customized solutions. Disadvantages include smaller scale and higher debt levels.

Major Acquisitions

Masterflex

  • Year: 2021
  • Acquisition Price (USD millions): 2300
  • Strategic Rationale: Expanding Avantor's single-use and fluid handling offerings, enhancing its biopharma capabilities.

Growth Trajectory and Initiatives

Historical Growth: Analyze historical revenue growth and profit margins over the past years. Refer to publicly available financials, including SEC filings (10-K, 10-Q).

Future Projections: Future projections are based on analyst estimates and industry trends. Refer to analyst reports from reputable financial institutions.

Recent Initiatives: Strategic initiatives include acquisitions, expansion of manufacturing capacity, and investment in R&D.

Summary

Avantor is a key player in the life sciences and advanced technologies industries, offering a diverse product portfolio and customized solutions. Its strategic acquisitions and global reach provide a strong foundation for future growth. However, the company faces challenges, including high debt levels and intense competition. Focus on integration and innovation will be key to sustained success.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • SEC Filings (10-K, 10-Q)
  • Company Website
  • Analyst Reports
  • Industry Research Reports

Disclaimers:

This analysis is for informational purposes only and should not be considered investment advice. Market share data is based on estimates and may not be precise. Past performance is not indicative of future results.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Avantor Inc

Exchange NYSE
Headquaters Radnor, PA, United States
IPO Launch date 2019-05-17
President & CEO Mr. Emmanuel Ligner
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 13500
Full time employees 13500

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.